Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.
Also called NCT07067658
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 300 participants
- Registry
-
NCT07067658
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT07067658. Randomized; quadruple masking; primary purpose prevention. Start 2025-12-18 (actual); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk
- Acronym
- ME-HF
- Condition
- Heart Failure
- Intervention (Device)
- Installation of Heartfelt Device
- Intervention (Other)
- Enhanced Standard care
- Intervention (Other)
- Questionnaires
- Intervention (Device)
- Heartfelt device alerting system
- Lead sponsor
- Heartfelt Technologies
- Collaborator
- Manchester University NHS Foundation Trust
- Collaborator
- University of Glasgow
Record details
- Record id
cardio:ct-nct07067658- Content hash
9d47e81799278d117e2137ca22209151902237a048c226ec25d80403bc00c0b8